Your healthcare provider is the one who should prescribe the treatments used for COVID-19. There are people who have been seriously harmed and even died after taking products not approved for COVID-19, even though they were products approved or prescribed for other uses.
Approved or authorized drugs
The Food and Drug Administration (FDA) has approved a drug, remdesivir (Veklury), for the treatment of COVID-19.
The FDA may also issue emergency use authorizations external icon (EUA) so that healthcare providers can use products that have not yet been approved, or that are approved for other uses, to treat patients. with COVID-19 if certain legal requirements are met.
The National Institutes of Health (NIH) created Treatment Guidelines external icon that they update frequently to guide healthcare providers caring for patients with COVID-19, including information on when clinicians might consider using any of the products reached by a USA.
Out of hospital treatment
Your healthcare provider may recommend the following to relieve symptoms and boost your body’s natural defenses:
Taking medicine, such as acetaminophen or ibuprofen, to lower a fever
Drink water or receive IV fluids to stay hydrated
Getting a good night’s rest can help your body fight the virus
If you are more likely to get very sick from COVID-19
Your healthcare provider may recommend that you have an experimental treatment.
For people at high risk of disease progression. The FDA has issued USAs for several investigational monoclonal antibodies that can adhere to parts of the virus. These antibodies could help the immune system to recognize and respond more effectively to the virus. The NIH COVID-19 Treatment Guidelines external icon provides information about these medications and describes what is known about their effectiveness. If used, they should be administered as soon as possible after diagnosis and within the first 10 days after disease onset. Your healthcare provider will decide if these experimental treatments are appropriate to treat your condition.
Slow down the activity of the virus. Antiviral drugs reduce the ability of the virus to multiply and spread through the body.
Reduce an excessive immune response. In patients with severe COVID-19, the immune system may over-respond to the threat of the virus, making the disease worse. This can damage the body’s organs and tissues. Some treatments can help reduce this excessive immune response.
Treat complications. COVID-19 can damage the heart, blood vessels, kidneys, brain, skin, eyes, and organs of the gastrointestinal system. It can also cause other complications. Depending on the complications, other seriously inpatient treatments, such as blood thinners, may be applied.
Contribute to the immune function of the body. Plasma from patients who have recovered from COVID-19 – called convalescent plasma – may contain antibodies to the virus. This could help the immune system recognize the virus and respond more effectively, but currently the NIH COVID-19 Treatment Guidelines external icon considers that there is insufficient evidence to recommend these treatments.